The tool reduces pathologist variability in liver biopsy assessment during trials of treatments for metabolic ...
Louisville Public Media on MSN2d
Eli Lilly's Alzheimer's drug not recommended by top European regulatorEli Lilly's Alzheimer's treatment is approved for use in the U.S. but the European Medicines Agency recommended against the ...
Pharmaceutical Technology on MSN10d
EMA to review GSK’s Nucala for COPD treatment expansionThe European Medicines Agency (EMA) has agreed to review GSK’s application of expanding Nucala’s (mepolizumab) use as add-on ...
SHANGHAI, China & JERSEY CITY, N.J.--(BUSINESS WIRE)--Shanghai Henlius Biotech, Inc. (2696.HK) and Organon (NYSE: OGN) today announced that the European Medicines Agency (EMA) has validated the ...
Organon and Shanghai Henlius Biotech have announced that the European Medicines Agency (EMA) has validated a marketing ...
CHMP recommends approval for XOANACYL, an oral therapy for use in the following therapeutic areas: Iron deficiency, chronic renal failure and ...
Variant, a company dedicated to developing innovative treatments for orphan inherited eye diseases, and the Rare Ocular Diseases Center at the University ofCampania Luigi Vanvitelli ...
Akebia Therapeutics gets EMA panel support for Xoanacyl to treat high phosphate & iron deficiency in CKD. Read more here.
The EMA’s Committee for Medicinal Products for Human Use said that a phase 3 study in children aged 3-14 years demonstrated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback